Novel Foods approval has “burnished the image” of curcuminoid ingredient 21-Feb-2022 By Lynda Searby Sabinsa has secured Novel Food approval for its patented curcuminoid metabolite ingredient C3 Reduct, giving supplement manufacturers in Europe a bioavailable curcuminoid option.